Hemolytic uremic syndrome following autologous peripheral blood stem cell transplantation in a patient with malignant lymphoma

Bone Marrow Transplantation

Volumn 19, Issue 10, 1997, Pages 1045-1047

  Ohno, E ^a   Ohtsuka, E ^a   Iwashita, T ^a   Uno, N ^a   Ogata, M ^a   Kikuchi, H ^a   Nasu, M ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

Hemolytic uremic syndrome; Methylprednisolone; Peripheral blood stem cell transplantation; Ticlopidine hydrochloride; Vincristine

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; METHYLPREDNISOLONE; MITOXANTRONE; PREDNISOLONE; TICLOPIDINE; VINCRISTINE;

ADULT; ARTICLE; AUTOTRANSPLANTATION; CASE REPORT; DRUG EFFICACY; HEMOLYTIC UREMIC SYNDROME; HUMAN; HUMAN CELL; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHODGKIN LYMPHOMA; ORAL DRUG ADMINISTRATION; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION;

EID: 0030906801     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1700791     Document Type: Article

References (10)

1. Pettitt AR, Clark RE. Thrombotic microangiopathy following bone marrow transplantation. Bone Marrow Transplant 1994; 14: 495-504.
2. Satoh K, Takahashi H, Nagai K, Shibata A. Thrombotic thrombocytopenic purpura and herpes zoster infection. Ann Intern Med 1988; 108: 154-155.
3. Oursler DP, Holley KE, Wagoner RD. Hemolytic uremic syndrome after bone marrow transplantation without total body irradiation. Am J Nephrol 1993; 13: 167-170.
4. Carlson K, Smedmyr B, Hagberg H et al. Haemolytic uraemic syndrome and renal dysfunction following BEAC (BCNU, etoposide, ara-C, cyclophosphamide) ± TBI and autologous BMT for malignant lymphomas. Bone Marrow Transplant 1993; 11: 205-208.
5. Raybon KB, Snyder MJ, Halvorson RD. Hemolytic uremic syndrome after autologous BMT without TBI. Bone Marrow Transplant 1996; 17: 897-898.
6. Juckett M, Perry EH, Daniels BS, Weisdorf DJ. Hemolytic uremic syndrome following bone marrow transplantation. Bone Marrow Transplant 1991; 7: 405-409.
7. Lelie H, Baars JW, Rodenhuis S et al. Hemolytic uremic syndrome after high dose chemotherapy with autologous stem cell support. Cancer 1995; 76: 2338-2342.
8. Sarode R, McFarland JG, Flomenberg N et al. Therapeutic plasma exchange does not appear to be effective in the management of thrombotic thrombocytopenic purpura/hemolytic uremic syndrome following bone marrow transplantation. Bone Marrow Transplant 1995; 16: 271-275.
9. Bobbio-Pallavicini E, Porta C, Centurion R et al. Vincristine sulfate for the treatment of thrombotic thrombocytopenic purpura refractory to plasma-exchange. Eur J Haematol 1994; 52: 222-226.
10. Tamura H, Mitarai T, Niimi Y et al. Late-onset renal dysfunction in a patient with non-Hodgkin's lymphoma following an autologous bone marrow transplantation. Jpn J Nephrol 1995; 37: 474-480.